Clinical Trial Update: Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating gemcitabine plus cisplatin with or without bintrafusp alfa (M7824) in first-line biliary tract cancer; study terminated with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Bintrafusp alfa (M7824) (bintrafusp alfa)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-06-13